This first edition was a great success, driven by inspiring talks and thought-provoking discussions. Vitiligo, a complex autoimmune disease, was at the heart of many conversations.

Marseille Immunology Biocluster (MIB), represented by Christel Navarro (Business Manager) and Carole Masurier (CEO), actively took part in discussions on the major current challenges in immunodermatology, including:

• the mechanisms behind the loss of immune tolerance,

• new therapeutic strategies in development,

• expectations from industry and clinicians,

• and the crucial importance of translational research for patient care.

We warmly thank the renowned experts who enriched the debates with their insightful contributions — John Harris, Mauro Picardo, Thierry Passeron, David Fisher, Hee Young Kang, Jean Krutmann, and Professor Goh Chee Leok — as well as Eurobiomed for the high quality of both the organization and the scientific exchange.

This event highlights the need for interdisciplinary collaboration to advance innovation for the benefit of patients.